BlackRock Fund Advisors - ARRAY BIOPHARMA INC ownership

ARRAY BIOPHARMA INC's ticker is ARRY and the CUSIP is 04269X105. A total of 171 filers reported holding ARRAY BIOPHARMA INC in Q4 2016. The put-call ratio across all filers is 0.59 and the average weighting 0.3%.

Quarter-by-quarter ownership
BlackRock Fund Advisors ownership history of ARRAY BIOPHARMA INC
ValueSharesWeighting
Q4 2016$65,779,000
+73.3%
7,483,416
+33.1%
0.01%
+50.0%
Q3 2016$37,956,000
+103.2%
5,623,151
+7.2%
0.01%
+100.0%
Q2 2016$18,680,000
+21.8%
5,247,300
+0.9%
0.00%0.0%
Q1 2016$15,339,000
-28.7%
5,199,679
+1.9%
0.00%
-20.0%
Q4 2015$21,523,000
-11.7%
5,100,339
-4.6%
0.01%
-16.7%
Q3 2015$24,379,000
-34.6%
5,346,211
+3.4%
0.01%
-33.3%
Q2 2015$37,272,000
-10.3%
5,169,481
-8.3%
0.01%
-10.0%
Q1 2015$41,532,000
+72.9%
5,635,297
+10.9%
0.01%
+66.7%
Q4 2014$24,026,000
+44.8%
5,079,429
+9.3%
0.01%
+20.0%
Q3 2014$16,587,000
-21.7%
4,646,266
-0.0%
0.01%
-16.7%
Q2 2014$21,188,000
-9.7%
4,646,525
-6.9%
0.01%
-14.3%
Q1 2014$23,468,000
-1.7%
4,993,088
+4.8%
0.01%0.0%
Q4 2013$23,865,000
-16.2%
4,763,543
+4.1%
0.01%
-30.0%
Q3 2013$28,463,000
+57.0%
4,576,113
+14.6%
0.01%
+42.9%
Q2 2013$18,131,0003,993,5800.01%
Other shareholders
ARRAY BIOPHARMA INC shareholders Q4 2016
NameSharesValueWeighting ↓
Redmile Group, LLC 17,224,428$281,103,00010.86%
BVF INC/IL 5,062,768$82,624,0008.38%
First Light Asset Management, LLC 1,675,148$27,338,0006.00%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 851,500$13,888,0005.42%
EcoR1 Capital, LLC 3,049,312$49,765,0004.99%
X-Square Capital, LLC 167,338$2,731,0002.88%
Eversept Partners, LP 357,727$5,838,1052.71%
SECTORAL ASSET MANAGEMENT INC 1,031,650$16,837,0001.85%
Copernicus Capital Management, LLC 131,418$2,145,0001.71%
Asymmetry Capital Management, L.P. 81,649$1,333,0001.67%
View complete list of ARRAY BIOPHARMA INC shareholders